256 related articles for article (PubMed ID: 28978038)
21. Spiral shape microfluidic channel for selective isolating of heterogenic circulating tumor cells.
Kwak B; Lee J; Lee J; Kim HS; Kang S; Lee Y
Biosens Bioelectron; 2018 Mar; 101():311-316. PubMed ID: 29055574
[TBL] [Abstract][Full Text] [Related]
22. Microfluidics and circulating tumor cells.
Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
[TBL] [Abstract][Full Text] [Related]
23. Continuous enrichment of circulating tumor cells using a microfluidic lateral flow filtration chip.
Lee SW; Hyun KA; Kim SI; Kang JY; Jung HI
J Chromatogr A; 2015 Jan; 1377():100-5. PubMed ID: 25542705
[TBL] [Abstract][Full Text] [Related]
24. Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients.
Hyun KA; Kwon K; Han H; Kim SI; Jung HI
Biosens Bioelectron; 2013 Feb; 40(1):206-12. PubMed ID: 22857995
[TBL] [Abstract][Full Text] [Related]
25. Highly sensitive enumeration of circulating tumor cells in lung cancer patients using a size-based filtration microfluidic chip.
Huang T; Jia CP; Jun-Yang ; Sun WJ; Wang WT; Zhang HL; Cong H; Jing FX; Mao HJ; Jin QH; Zhang Z; Chen YJ; Li G; Mao GX; Zhao JL
Biosens Bioelectron; 2014 Jan; 51():213-8. PubMed ID: 23962709
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.
Beasley AB; Isaacs TW; Vermeulen T; Freeman J; DeSousa JL; Bhikoo R; Hennessy D; Reid A; Chen FK; Bentel J; McKay D; Conway RM; Pereira MR; Mirzai B; Calapre L; Erber WN; Ziman MR; Gray ES
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885099
[TBL] [Abstract][Full Text] [Related]
27. Continuous Separation of Circulating Tumor Cells from Whole Blood Using a Slanted Weir Microfluidic Device.
Yoon Y; Lee J; Ra M; Gwon H; Lee S; Kim MY; Yoo KC; Sul O; Kim CG; Kim WY; Park JG; Lee SJ; Lee YY; Choi HS; Lee SB
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30744156
[TBL] [Abstract][Full Text] [Related]
28. [Advances in isolation and enrichment of circulating tumor cells in microfluidic chips].
Du J; Liu X; Xu X
Se Pu; 2014 Jan; 32(1):7-12. PubMed ID: 24783862
[TBL] [Abstract][Full Text] [Related]
29. Novel Isolating Approaches to Circulating Tumor Cell Enrichment Based on Microfluidics: A Review.
Qiao Z; Teng X; Liu A; Yang W
Micromachines (Basel); 2024 May; 15(6):. PubMed ID: 38930676
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic technologies for circulating tumor cell isolation.
Cho H; Kim J; Song H; Sohn KY; Jeon M; Han KH
Analyst; 2018 Jun; 143(13):2936-2970. PubMed ID: 29796523
[TBL] [Abstract][Full Text] [Related]
31. Enrichment of Circulating Tumor Cells from Whole Blood Using a Microfluidic Device for Sequential Physical and Magnetophoretic Separations.
Lee J; Sul O; Lee SB
Micromachines (Basel); 2020 May; 11(5):. PubMed ID: 32384825
[TBL] [Abstract][Full Text] [Related]
32. Enrichment of circulating head and neck tumour cells using spiral microfluidic technology.
Kulasinghe A; Tran TH; Blick T; O'Byrne K; Thompson EW; Warkiani ME; Nelson C; Kenny L; Punyadeera C
Sci Rep; 2017 Feb; 7():42517. PubMed ID: 28198401
[TBL] [Abstract][Full Text] [Related]
33. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
34. Label-Free Isolation and mRNA Detection of Circulating Tumor Cells from Patients with Metastatic Lung Cancer for Disease Diagnosis and Monitoring Therapeutic Efficacy.
Wang J; Lu W; Tang C; Liu Y; Sun J; Mu X; Zhang L; Dai B; Li X; Zhuo H; Jiang X
Anal Chem; 2015 Dec; 87(23):11893-900. PubMed ID: 26531886
[TBL] [Abstract][Full Text] [Related]
35. Dual-Isolation and Profiling of Circulating Tumor Cells and Cancer Exosomes from Blood Samples with Melanoma Using Immunoaffinity-Based Microfluidic Interfaces.
Kang YT; Hadlock T; Lo TW; Purcell E; Mutukuri A; Fouladdel S; Raguera MS; Fairbairn H; Murlidhar V; Durham A; McLean SA; Nagrath S
Adv Sci (Weinh); 2020 Oct; 7(19):2001581. PubMed ID: 33042766
[TBL] [Abstract][Full Text] [Related]
36. A microfluidic device for label-free, physical capture of circulating tumor cell clusters.
Sarioglu AF; Aceto N; Kojic N; Donaldson MC; Zeinali M; Hamza B; Engstrom A; Zhu H; Sundaresan TK; Miyamoto DT; Luo X; Bardia A; Wittner BS; Ramaswamy S; Shioda T; Ting DT; Stott SL; Kapur R; Maheswaran S; Haber DA; Toner M
Nat Methods; 2015 Jul; 12(7):685-91. PubMed ID: 25984697
[TBL] [Abstract][Full Text] [Related]
37. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
[TBL] [Abstract][Full Text] [Related]
38. Electrical Detection Method for Circulating Tumor Cells Using Graphene Nanoplates.
Han SI; Han KH
Anal Chem; 2015 Oct; 87(20):10585-92. PubMed ID: 26402053
[TBL] [Abstract][Full Text] [Related]
39. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
[TBL] [Abstract][Full Text] [Related]
40. Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment.
Gray ES; Reid AL; Bowyer S; Calapre L; Siew K; Pearce R; Cowell L; Frank MH; Millward M; Ziman M
J Invest Dermatol; 2015 Aug; 135(8):2040-2048. PubMed ID: 25830652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
